Home 
Fresenius Group
Fresenius Group 
Page 1 of 2
Fresenius is a health care group providing products and services for dialysis, hospitals and the medical care of patients at home. In addition, Fresenius focuses on hospital operation, as well as on engineering and services for hospitals and other health care facilities. About 122,000 employees have dedicated themselves to the service of health in about 100 countries worldwide.
| FRESENIUS GROUP IN FIGURES | |||||
| in million € | 2008 | 2007 | 2006 | 2005 | 2004 |
| Earnings | |||||
| Sales | 12,336 |
11,358 | 10,777 | 7,889 | 7,271 |
| EBIT | 1,7271) |
1,609 | 1,444 | 969 | 845 |
| Net income | 4501) |
410 | 330 | 222 | 168 |
| Depreciation and amortization | 783 |
421 | 399 | 320 | 315 |
| Operating cash flow | 1,074 |
1,296 | 1,052 | 780 | 851 |
| Operating cash flow in % of sales | 8.7% |
11.4% | 9.8% | 9.9% | 11.7% |
| Earnings per ordinary share in € | 2.851) |
2.64 | 2.158) | 1.768) | 1.368) |
| Earnings per preference share in € | 2.861) | 2.65 | 2.168) | 1.778) | 1.378) |
| Balance sheet |
|||||
| Total assets | 20,544 | 15,324 | 15,024 | 11,594 | 8,188 |
| Non-current assets | 15,466 | 11,033 | 10,918 | 8,063 | 5,433 |
| Equity2) | 6,943 | 6,059 | 5,728 | 5,130 | 3,347 |
| Equity ratio2) | 34% | 40% | 38% | 44% | 41% |
| Investments 3) | 4,617 | 1,318 | 4,314 | 2,247 | 421 |
| Profitability |
|||||
| EBIT margin | 14.0%1) | 14.2% | 13.4% | 12.3% | 11.6% |
| Return on equity after taxes (ROE) 4) 6) 9) | 10.5% | 12.0% | 10.4% | 11.4% | 10.5% |
| Return on operating assets (ROOA) 4) 5) 9) | 9.8% | 11.4% | 10.4% | 11.7% | 11.1% |
| Return on invested capital (ROIC) 4) 5) 9) | 7.3% | 8.4% | 7.4% | 8.0% | 7.4% |
| Dividend per ordinary share in € | 0.707) | 0.66 | 0.57 | 0.498) | 0.458) |
| Dividend per preference share in € | 0.717) | 0.67 | 0.58 | 0.508) | 0.468) |
| Employees (December 31) | 122,217 | 114,181 | 104,872 | 91,971 | 68,494 |
| 1) | Before special items from the APP acquisition |
| 2) | Equity including minority interest |
| 3) | Investments in property, plant and equipment and intangible assets, acquisitions |
| 4) | 2005: balance sheet adjusted for acquisition of HELIOS Kliniken |
| 5) | 2006 pro forma Renal Care Group, excluding earnings from the divestiture of US dialysis clinics as well as their first quarter 2006 earnings |
| 6) | 2006 pro forma Renal Care Group, excluding first quarter 2006 earnings of divested US dialysis clinics |
| 7) | Proposal |
| 8) | Adjusted for share split in February 2007 |
| 9) | 2008 pro forma APP Pharmaceuticals and excluding special items from the acquisition |
| You will find a 10-year overview on our website: www.fresenius.com/Investor Relations. | |
-
1 of 2
-
1
2
-
1
2
-
1 of 2
-
1
2
-
1
2